FeesSafety
Pluang+

NextPlat reports 72% rise in high-margin 340B prescription volumes, cuts net loss by 66% in Q3 2026

Company Fundamentals
12 Nov 2026, 15:01 WIB
PRNewsWire
View Source
Bullish
NextPlat reports 72% rise in high-margin 340B prescription volumes, cuts net loss by 66% in Q3 2026

NextPlat Corp announced a 72% increase in higher-margin 340B prescription volumes in Q3 2026, driving significant growth in contracted pharmacy services. Despite a revenue drop to $10.5 million due to lower reimbursement rates and retail volumes, gross margins improved to 35%, with healthcare operations margins rising to 41%. The company reduced its net loss by 66% to $0.7 million, expanded its pharmacy footprint with new locations in Pensacola and Jacksonville, and plans further growth through acquisitions and new e-commerce healthcare services. These developments position NextPlat for stronger profitability and market expansion in 2027.

NextPlat's Q3 financial results provide context for readers following healthcare developments. As of Nov 12, 2026 19:11 WIB, 91 of 150 health-sector US stocks on Pluang rose while 53 fell. Notable movers include MiniMed Group Inc. at USD 17.50 with a -4.11% change, Maravai LifeSciences Holdings Inc. at USD 7.94 with a +3.12% change, and Twist Bioscience Corp at USD 118.77 with a -3.12% change and 100% buy order activity.

More News

Evaxion announces its 2027 financial calendar with key dates for updates and results.

Evaxion announces its 2027 financial calendar with key dates for updates and results.

Evaxion, a clinical-stage TechBio company, has released its financial calendar for 2027, outlining important dates for business updates and financial results. Key events include the full year 2026 results on March 4, the Annual General Meeting on Apr...

Market News
Neutral
59 minutes ago
CollPlant to trade as OPHI on Nasdaq, focusing on photonic computing with LightSolver's laser tech.

CollPlant to trade as OPHI on Nasdaq, focusing on photonic computing with LightSolver's laser tech.

CollPlant Biotechnologies will change its Nasdaq ticker from CLGN to OPHI starting November 13, 2026, reflecting its strategic shift toward photonic computing through its subsidiary LightSolver. This move highlights CollPlant's focus on developing Li...

Market News
Bullish
59 minutes ago
Glider launches a permissionless platform for tokenized stocks amid public companies' rejection of SEC venues.

Glider launches a permissionless platform for tokenized stocks amid public companies' rejection of SEC venues.

Glider has introduced a global investing platform for tokenized stocks that operates permissionlessly, bypassing the SEC's Tokenized Securities Venues (TSVs) which 50 public companies recently rejected. Backed by major investors like a16z and Coinbas...

Market News
Bullish
59 minutes ago
BofA raises Royal Caribbean price target to $365 on strong bookings and 2027 earnings outlook

BofA raises Royal Caribbean price target to $365 on strong bookings and 2027 earnings outlook

BofA Securities raised its price target for Royal Caribbean Group to $365, citing strong booking volumes and the company’s goal of adjusted earnings per share around $20 by 2027. The cruise operator expects 4.5% capacity growth next year and has repo...

Analyst Insights
Bullish
1 hour ago
Tilray's 10 Barrel, Widmer Brothers, and Hop Valley named official craft beer partners of Portland Trail Blazers.

Tilray's 10 Barrel, Widmer Brothers, and Hop Valley named official craft beer partners of Portland Trail Blazers.

Tilray Brands announced that its subsidiaries 10 Barrel Brewing, Widmer Brothers Brewing, and Hop Valley Brewing are now the official craft beer partners of the Portland Trail Blazers. This partnership expands the availability of Oregon craft beers a...

Market News
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App